Tedeschi, R, Foong, Y T, Cheng, H M et al. · The Journal of general virology · 1995 · DOI
This study looked at antibody patterns against a specific EBV protein called ZEBRA, which becomes active when the virus 'wakes up' from dormancy. Researchers found that different parts of this protein trigger antibodies in different diseases—some patterns were more common in people with nasopharyngeal cancer, others in people with infectious mononucleosis, and some in people with chronic fatigue syndrome. This suggests that the type of EBV reactivation may differ depending on the illness someone has.
ME/CFS patients often show evidence of EBV reactivation, and understanding which specific viral epitopes are targeted in different conditions could help clarify whether EBV activation in ME/CFS follows a distinct immunological pattern. This work provides a framework for distinguishing different types of EBV reactivation, which may eventually aid in understanding ME/CFS disease heterogeneity and pathology.
This study does not prove that ZEBRA antibodies cause ME/CFS or any other disease—it only describes serological associations. The findings are correlational and cannot establish whether EBV reactivation is a primary driver of ME/CFS symptoms or a secondary consequence. Additionally, the ME/CFS group's results are not detailed in the abstract, so the specific antibody patterns in ME/CFS patients remain unclear.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →